JG

Jan Garfinkle

Managing Partner at Arboretum Ventures

Detroit Metropolitan Area

Overview 

Jan Garfinkle is the Founder and Managing Partner of Arboretum Ventures, specializing in healthcare venture financing and board leadership. With a background in strategic planning and entrepreneurship, Jan has successfully invested in companies like AtaCor Medical and Reprieve Cardiovascular, contributing to their growth and success in the healthcare sector.

Work Experience 

  • Managing Partner, Founder

    2002 - Current

    Arboretum Ventures was founded based on the belief that through innovation we can remove costs from the healthcare system, while still providing excellent clinical care. We believe in investing in entrepreneurs with a similar vision, who are capital efficient, and have a significant drive to change healthcare.

  • Board Member, Investor

    2024

AtaCor Medical is a medical device maker.

Raised $62,000,000.00 from baymed venture partners, Longview Ventures, Catalyst Health Ventures, Arboretum Ventures and Hatteras Venture Partners.

  • Board Member, Investor

    2023

Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.

Raised $91,050,001.00 from Deerfield Management, Lightstone Ventures, Sante Ventures, Genesis Capital, Arboretum Ventures and Deerfield.

  • Board Member, Investor

    2021

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Raised $96,000,000.00 from Agilent Technologies, GKCC, Ron Seubert, The Forest Road Company, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, 5AM Ventures and Sheatree Capital.

  • Board Member, Investor

    2018

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.

Raised $77,000,000.00 from Solas BioVentures, Tonkawa Investments, H2Oey Ventures, Arboretum Ventures and Coloplast.

  • Board Member, Investor

    2020

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

Raised $70,224,957.00 from OrbiMed.

  • Board Member, Investor

    2016

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Raised $128,000,000.00 from Wellington Management, Baird Capital, Cormorant Asset Management, Pfizer Venture Investments, Highline Capital Management, Arboretum Ventures, Deerfield, Merck Global Health Innovation Fund, Monashee Investment Management and Renaissance Venture Capital.

  • Board Member

    2011

Bank of Ann Arbor is a financial institution that provides banking services to clients with total assets.

  • Board Member

    2017 - 2023

As CommonSpirit Health, we make the healing presence of God known in our world by improving the health of the people we serve.

  • Board Member, Investor

    2012 - 2020

    Acquired by QIAGEN N.V., September 2020

Articles About Jan

Relevant Websites